Daily Program
6:30 pm – 8:30 pm |
Welcome Reception |
|
|
7:00 am – 8:00 am |
Breakfast |
|
8:00 am – 10:00 am |
Oral Abstract Session 1: Regulation of Allergic InflammationChair: R. Stokes Peebles, United States |
|
|
8:00 am – 8:20 am |
Identification of a Human Th2 Multipotent Progenitor |
Patrick J. Brennan, United States |
|
8:20 am – 8:40 am |
Epithelial-Intrinsic Defects In TGFβR Signaling Drive the Development of Eosinophilic Esophagitis |
Pamela Guerrerio, United States |
|
8:40 am – 9:00 am |
Preventive but not Therapeutic Administration of a Bacterial Lysate Suppresses Experimental Allergic Asthma |
Vadim Pivniouk, United States |
|
9:00 am – 9:20 am |
Enhanced ST2 Expression is Associated with Pathogenicity in Treg Lacking PGI2 Signaling |
Allison E. Norlander, United States |
|
9:20 am – 9:40 am |
IL-4R⍺ Signaling Drives Mast Cell-Derived Oncostatin M and an Innate Inflammatory Response in AERD |
Tanya M. Laidlaw, United States |
|
9:40 am – 10:00 am |
Asthma-protective Agents in Dust from Traditional Farm Environments |
Donata Vercelli, United States |
|
10:00 – 10:30 am |
Break |
|
10:30 am – 11:20 am |
Keynote Lecture: IgE, FcεRI, and NumbersChair: Bruce S. Bochner, United States |
Donald W. MacGlashan, Jr., United States |
11:30 am – 12:30 am |
Oral Abstract Session 2: B Cells and Allergic DiseasesChair: Mübeccel Akdis, Switzerland |
|
|
11:30 am – 11:50 am |
A Distinct Phenotype of Polarized Memory B Cell Holds IgE Memory |
Allyssa Phelps, Canada |
|
11:50 am – 12:10 pm |
Pathogenic IgE-Fated B Cell Memory Retains Functional Plasticity |
Atai Ariaz, Canada |
|
12:10 pm – 12:30 pm |
Antibody Affinity Birth Through Somatic Hypermutation |
Duane Wesemann, United States |
|
12:30 pm – 2:00 pm |
Lunch |
|
12:30 pm – 2:00 pm |
Satellite Symposium: A Focus on Type 2 Inflammation in DiseaseSpeaker: Leonard Bacharier, United States Sponsored by: |
|
2:00 pm – 3:40 pm |
Oral Abstract Session 3: Type 2 Inflammation PathobiologyChair: Sven-Erik Dahlén, Sweden |
|
|
2:00 pm – 2:20 pm |
Platelet-Derived Cysteinyl Leukotrienes Drive Sexually Dimorphic Features of Type 2 Inflammation |
Joshua A. Boyce, United States |
|
2:20 pm – 2:40 pm |
House Dust Mite Allergen Induces PAR-1 Dependent Release of Calcitonin-Gene Related Peptide from Cultured Human Pulmonary Neuroendocrine Cells |
Paul Forsythe, Canada |
|
2:40 pm – 3:00 pm |
Oxidatively Driven Programmed Cell Death and Mitophagic Survival Converge to Alter Epithelial Cell Phenotypes and Function of Relevance to Asthma |
Sally E. Wenzel, United States |
|
3:00 pm – 3:20 pm |
Contribution of Oleoylethanolamide and CB2 receptor in Eosinophilic Airway Inflammation of Bronchial Asthma |
Ga Young Ban, Korea |
|
3:20 pm – 3:40 pm |
Mechanism of Innate Memory Formation in ILC2s and its Relevance for Asthma |
Rafeul Alam, United States |
|
3:40 pm – 4:00 pm |
Break |
|
4:00 pm – 4:50 pm |
Relaxing Lecture: Misinformation: The Battle Continues!Chair: Judah Denburg, Canada |
Timothy Caulfield, Canada |
5:00 pm – 5:30 pm |
Poster Lightning Round 1Chair: Jean Marshall, Canada |
|
|
5:00 pm – 5:03 pm |
Dysregulated Immune Landscape of Persistent COVID19 Olfactory Dysfunction |
Lora Bankova, United States |
|
5:03 pm – 5:06 pm |
Why African American Children with Food Allergy have Higher Risk of Asthma: Studying the Interrelated Links of Health Disparities, Environment and Microbiome |
Mahboobeh Mahdavinia, United States |
|
5:06 pm – 5:09 pm |
Characterization of a T follicular Helper Cell Subset in a Monogenic form of Food Allergy |
Stephanie C. Eisenbarth, United States |
|
5:09 pm – 5:12 pm |
Receptor-Ligand Interaction Between GPR15+ T Cells and GPR15L May Facilitate the Extravasation of T Cells Into the Esophageal Mucosa in Eosinophilic Esophagitis (EoE) |
Moumita Bhowmik, United States |
|
5:12 pm – 5:15 pm |
Drug-induced Anaphylaxis Uncommon Among 252 Patients with Mastocytosis |
Theo Gulen, Sweden |
|
5:15 pm – 5:18 pm |
Risk of Childhood Wheeze and Asthma Associated with Grandparental Asthma in a Three Generations Cohort |
Syed H. Arshad, United Kingdom |
|
5:18 pm – 5:21 pm |
Taurine and Sphingolipid Metabolites Identify Unique Response Signatures to Omalizumab and Mepolizumab in Asthma |
Ayobami Akenroye, United States |
|
5:21 pm – 5:24 pm |
Elucidation of the Underlying Mechanism of Itching in Atopic Dermatitis |
Kenji Izuhara, Japan |
|
5:24 pm – 5:27 pm |
Cytokine Stimulation of Airway Mucins |
Kristina Johansson, Sweden |
|
5:27 pm – 5:30 pm |
Maternal Atopic History is Associated with Decreased TLR2 and GM-CSFR Expression on Infant Hematopoietic Progenitor Cells |
David M. Putman, Canada |
5:30 pm – 7:30 pm |
Poster Session 1 |
|
COVID-19 and Allergic Disease |
||
|
SARS-CoV-2 Infection in Pregnancy Alters Maternal and Cord Blood Immune Cell Composition and Function at Delivery |
David M. Putman, Canada |
|
|
Characterizing the Release of the Proinflammatory Cytokine TSLP from Lung Epithelial Cells in Response to SARS-CoV-2 Infection |
Luke Gerla, Canada |
|
|
Dysregulated Immune Landscape of Persistent COVID19 Olfactory Dysfunction |
Lora Bankova, United States |
|
|
Effects of Age and Wildfire Smoke Exposure on Anti-SARS-CoV-2 Vaccine Immunity: Role of Natural Killer Cells |
Gursharan Kaur Sanghar, United States |
|
Food and Drug Allergies and Gastrointestinal Disorders |
||
|
Why African American Children with Food Allergy have Higher Risk of Asthma: Studying the Interrelated Links of Health Disparities, Environment and Microbiome |
Mahboobeh Mahdavinia, United States |
|
|
Characterization of a T follicular Helper Cell Subset in a Monogenic form of Food Allergy |
Stephanie C. Eisenbarth, United States |
|
|
Dietary Intervention in LTP Allergic Patients: Safety and Clinical Response |
Maria J. Torres, Spain |
|
|
Receptor-Ligand Interaction Between GPR15+ T Cells and GPR15L May Facilitate the Extravasation of T Cells into the Esophageal Mucosa in Eosinophilic Esophagitis (EoE) |
Moumita Bhowmik, United States |
|
Genomics, Environmental Factors and Precision Medicine |
||
|
Risk of Childhood Wheeze and Asthma Associated with Grandparental Asthma in a three generations cohort |
Syed H. Arshad, United Kingdom |
|
|
Taurine and Sphingolipid Metabolites Identify Unique Response Signatures to Omalizumab and Mepolizumab in Asthma |
Ayobami Akenroye, United States |
|
|
Transcriptional Gene Networks in the Lungs of Mice Exposed to Asthma-Protective Microbial Agents: A Comparative Analysis |
Sydney VanLinden, United States |
|
|
Epidemiological Transition of Wheezing-associated Viruses. The Role of New Viruses |
Alejandra Osorio Martínez, Mexico |
|
Pathophysiology of Allergic Disorders and Inflammation |
||
|
Which is Important for the Pathogenesis of Allergic Bronchopulmonary Aspergillosis/Mycosis, IgE or Eosinophils? |
Koichiro Asano, Japan |
|
|
Trained Immunity and Macrophage Reprogramming in Allergic Asthma |
Jiu-Yao Wang, Taiwan |
|
|
Exploring the Therapeutic Potential of Probiotic-Derived Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Protein as an Anti-Allergy Agent |
Pei-Chi Chen, Taiwan |
|
|
Impact of Circulating Angiomotin and Angiostatin on Clinical Variables in Patients with Asthma |
An Soo Jang, Korea |
|
|
Elucidation of the Underlying Mechanism of Itching in Atopic Dermatitis |
Kenji Izuhara, Japan |
|
|
Cytokine Stimulation of Airway Mucins |
Kristina Johansson, Sweden |
|
|
Maternal Atopic History is Associated with Decreased TLR2 and GM-CSFR Expression on Infant Hematopoietic Progenitor Cells |
David M. Putman, Canada |
|
|
Growth Patterns and Asthma in Early Childhood: The CHILD Cohort Study |
Padmaja Subbarao, Canada |
|
|
Relevance of sIgE and sIgG4 to Cat and Dust Mite Allergens in relation to Asthma in the Project Viva Birth Cohort: The Modified Th2 Response Revisited |
Thomas A.E. Platts-Mills, United States |
|
|
Circulating MicroRNA in Different Courses of Atopic Dermatitis |
Nadine Herrmann, Germany |
|
|
Combined Metagenomic - and Culture-Based Approaches to Investigate Bacterial Strain-Level Associations with Medication-Controlled Mild-Moderate Atopic Dermatitis |
Anne Marie Singh, United States |
|
|
Overexpression of miR-29b in Bronchial Biopsies from Individuals with Asthma Coincides with Reduced Levels of Soluble ST2 in Bronchial Lavage Fluid |
Madeleine Rådinger, Sweden |
|
|
Demographic Encoded Phenotypes in Atopic Dermatitis and Related QoL- Cross Sectional Results from the ProRaD-study in 1011 patients |
Laura Maintz, Germany |
|
|
Characterization of Extracellular Vesicles in the Peripheral Blood Of Atopic Dermatitis Patients |
Pierre-Yves Mantel, Switzerland |
|
|
Oxidative-stress-induced Glucocorticoid Insensitivity in Human Airway Smooth Muscles In Vitro and Asthmatic Rhesus Macaques In Vivo |
Angela Haczku, United States |
|
|
CFTR Regulates Airway Epithelial IL-33 Release and IL-33 Dependent Inflammation |
R. Stokes Peebles Jr., United States |
|
Urticaria, Angioedema, Anaphylaxis, Mastocytosis and Mast Cell Activation Disorders |
||
|
Hereditary A-tryptasemia is Associated with Increased Risk for Anaphylaxis to Antibiotics and Biological Agents |
Peter Korosec, Slovenia |
|
|
Minding the Gap Between Anaphylaxis Guidelines and Clinical Practice in Emergency Departments Across Age Groups |
Tsung-Chieh Yao, Taiwan |
|
|
Drug-induced Anaphylaxis Uncommon Among 252 Patients with Mastocytosis |
Theo Gulen, Sweden |
|
|
Differential Urinary Mast Cell Mediators in Mastocytosis, Hereditary Alpha Tryptasemia and Atopic Patients |
Mariana C. Castells, United States |
|
|
Treatment with the KIT Antibody Barzolvolimab Leads to a Profound Depletion of Skin Mast Cells and to Novel Insights into the Therapy of Mast Cell-driven Diseases |
Diego Alvarado, United States |
|
|
7:00 am – 8:00 am |
Breakfast |
|
8:00 am – 9:20 am |
Oral Abstract Session 4: Mast CellsChair: Stephen Galli, United States |
|
|
8:00 am – 8:20 am |
Defining the Expression and Function of Siglec-9 and its Ligands on Mast Cells |
Adrian Piliponsky, United States |
|
8:20 am – 8:40 am |
Human Intraepithelial Mast Cell Differentiation and Effector Function are Directed by TGF-β Signaling |
Daniel F. Dwyer, United States |
|
8:40 am – 9:00 am |
IgG:FcɣRIIb Signals Block Effector Programs of IgE:FcεRI-activated Mast Cells |
Cynthia Kanagaratham, United States |
|
9:00 am – 9:20 am |
Activation of the Mas-Related G protein-Coupled Receptor MRGPRX2 with Substance P Analogs Demonstrates the Importance of Key Residues |
Marianna Kulka, Canada |
|
9:20 am – 10:00 am |
Break |
|
10:00 am – 10:50 am |
Carl Prausnitz Lecture: Insights into Atopic DermatitisChair: Donata Vercelli, United States |
Raif Geha, United States |
|
11:00 am – 12:15 pm |
Pro/Con Debate: Biologics have Solved the Problem of Type 2 AsthmaChair: Stephen T. Holgate, United Kingdom Pro: Parameswaran Nair, Canada Lunch provided |
|
12:30 pm – 4:30 pm |
Optional Boat Ride |
|
5:00 pm – 5:30 pm |
Poster Lightning Round 2Chair: Roma Sehmi, Canada |
|
|
5:00 pm – 5:03 pm |
Allergen-specific Type 2 Memory B Cells in Bee Venom Allergy are Modified Following Ultra-Rush Immunotherapy |
Menno C. Van Zelm, Australia |
|
5:03 pm – 5:06 pm |
Novel Variants of Epitope 1 of Ara h 2 have Enhanced IgE Binding that Varies Among Subjects |
Stephen C. Dreskin, United States |
|
5:06 pm – 5:09 pm |
Neuregulin-1 Partially Overcomes the Requirement for CD11c Expressing Cells to Survive a Respiratory Viral Infection |
Mitchell H. Grayson, United States |
|
5:09 pm – 5:12 pm |
The Dermal Fibroblast Phenotype Determines Skin Mast Cell Reactivity |
Anna Di Nardo, United States |
|
5:12 pm – 5:15 pm |
TSLP Trafficking in Allergen-Treated Airway Epithelial Cells: Colocalization with Rab11a Guanosine Triphosphatase |
Marc Duchesne, Canada |
|
5:15 pm – 5:18 pm |
Comprehensive Profiling of Lipid Mediator Metabolites in Human Lung Mast Cells Reveals Selective Production Following IgE-dependent Activation |
Anna-Karin Johnsson, Sweden |
|
5:18 pm – 5:21 pm |
Annexin A1 is a Cell-Intrinsic Regulator of Human Group 2 Innate Lymphoid Cells Via Zinc |
Hiroki Kabata, Japan |
|
5:21 pm – 5:24 pm |
Metabolomics of Circulating Human Memory CD4+T effector and T regulatory Cells Reveals that Phenylalanine is a Metabolic Checkpoint of Pathogenic Th2 Cells Development |
Milena Sokolowska, Switzerland |
|
5:24 pm – 5:27 pm |
Effective Delivery of miR-511-3p with Mannose-Decorated Exosomes with RNA Nanoparticles Confers Protection against Asthma |
Peisong Gao, United States |
|
5:27 pm – 5:30 pm |
A Surfactant Protein-A Peptide Modulates Responses to Interleukin-13 in Asthma and Offers a Novel Therapeutic Alternative |
Monica Kraft, United States |
5:30 pm – 7:30 pm |
Poster Session 2 |
|
Allergen Specific Immunotherapy |
||
|
Allergen-specific Type 2 Memory B Cells in Bee Venom Allergy are Modified Following Ultra-Rush Immunotherapy |
Menno C. Van Zelm, Australia |
|
|
Modified Tree Nut Desensitization Protocol in Real-World Clinical Practice |
Adnan M. Al Ali, Canada |
|
|
Uniform Pulse of Th2 IL-6 Signaling and IL-10-Producing B Cells Marks the Initial Immune Switch in Insect Venom Allergen Immunotherapy |
Markus Ollert, Luxembourg |
|
|
Allergen-Neutralizing IgG Rapidly Rises In Dogs Vaccinated With Der f 2-Expressing Bioparticles |
Guy Tropper, Canada |
|
Allergens and Diagnosis of Allergy |
||
|
In 12 Years Skin Prick Test Sensitization in Mexican Patients with Respiratory Allergy Increased and Differs Between Humid and Dry Zones |
Désirée E. Larenas Linnemann, Mexico |
|
|
Rapid Point-of-care Detection of EPX in Sputum |
Parameswaran Nair, Canada |
|
|
Novel Variants of Epitope 1 of Ara h 2 Have Enhanced IgE Binding That Varies Among Subjects |
Stephen C. Dreskin, United States |
|
|
Developing a Pipeline for the Characterization of Allergen Content and Adjuvant Activity of Allergen-Displaying Plant Bioparticles |
Lorenz Aglas, Austria |
|
Dendritic Cells, Mast Cells, Monocytes/Macrophages, Neutrophils, Eosinophils, Basophils and Epithelial Cells |
||
|
Neuregulin-1 Partially Overcomes the Requirement for CD11c Expressing Cells to Survive a Respiratory Viral Infection |
Mitchell H. Grayson, United States |
|
|
Muscarinic M3 Receptor Involves in the Differentiation of M2 Macrophage in Allergic Airway Inflammation |
Shin Ohta, Japan |
|
|
Exosomal Let-7-mediated Regulation of Lipid Metabolism in Foamy Macrophage of Chronic Obstructive Pulmonary Disease (COPD) |
Miao-Hsi Hsieh, Taiwan |
|
|
Expression and Functions of Proteinase-Activated Receptor-2 in Human Intermediate Monocytes |
Harissios Vliagoftis, Canada |
|
|
TSLP Trafficking in Allergen-Treated Airway Epithelial Cells: Colocalization with Rab11a Guanosine Triphosphatase |
Marc Duchesne, Canada |
|
|
The Dermal Fibroblast Phenotype Determines Skin Mast Cell Reactivity |
Anna Di Nardo, United States |
|
|
Comprehensive Profiling of Lipid Mediator Metabolites in Human Lung Mast Cells Reveals Selective Production Following IgE-dependent Activation |
Anna-Karin Johnsson, Sweden |
|
|
A Novel Isoprenylation Inhibitor Suppresses Asthma-related Mast Cell Function |
John J. Ryan, United States |
|
|
How Flexible are Neutrophils to Opposing Signals? |
Paola Andrea Martinez Murillo, Switzerland |
|
|
Interleukin-5 Modifies The Expression Of Selected Interleukin-6 Family Members By Human Mast Cells And Enhances Mast Cell Interferon Responses |
Jean Marshall, Canada |
|
Lymphocytes and Mediators of Immunoregulation |
||
|
Annexin A1 is a Cell-Intrinsic Regulator of Human Group 2 Innate Lymphoid Cells Via Zinc |
Hiroki Kabata, Japan |
|
|
Neuromedin-U/ NMU-R1 Axis Mediates Rapid Activation of Group 2 Innate Lymphoid Cells in the Airways following inhaled Allergen Challenge in Subjects with Mild Asthma |
Roma Sehmi, Canada |
|
|
Metabolomics of Circulating Human Memory CD4+T effector and T regulatory Cells Reveals that Phenylalanine is a Metabolic Checkpoint of Pathogenic Th2 Cells Development |
Milena Sokolowska, Switzerland |
|
|
Differences In Th2 Population Sizes Between Atopic and Non-atopic Toddlers are not Established Until 36 Months of Age |
Caitlin M. Burk, United States |
|
|
Elevated CD27-IgD Double Negative B Cells in Eosinophilic Granulomatosis with Polyangiitis Patients Associated with Serum Anca Status |
Nadia Suray Tan, Canada |
|
|
Histidine Decarboxylase Expression in Human CD4 T cells |
Binh Nguyen, Canada |
|
Treatment of Non-Allergic Immune Disorders |
||
|
Effective Delivery of miR-511-3p with Mannose-Decorated Exosomes with RNA Nanoparticles Confers Protection against Asthma |
Peisong Gao, United States |
|
|
New Outcomes on the Role of Histamine H4R and Gilz Anti-inflammatory Effects in Bleomycin-induced Pulmonary Fibrosis Model |
Laura Lucarini, Italy |
|
|
High Prevalence of Airway Hyperresponsiveness Among Adults with Symptomatic Asthma and Comorbid Obesity |
Katherine Cahill, United States |
|
|
A Surfactant Protein-A Peptide Modulates Responses to Interleukin-13 in Asthma and Offers a Novel Therapeutic Alternative |
Monica Kraft, United States |
|
|
The Concept of Disease Modification in Atopic Dermatitis: Scientific and Regulatory Challenges for Drug Discovery and Development |
Thomas Bieber, Germany |
|
|
Characterization of Intrinsic Atopic Dermatitis Revisited using Multiplex Allergy Diagnostics |
Thomas Bieber, Germany |
|
|
The Severity of Allergic Rhinitis is Related to Sleep Disturbances in Korean Children and Adolescents |
Yeong Ho Rha, Korea |
|
|
7:00 am – 8:00 am |
Breakfast |
|
8:00 am – 10:00 am |
Oral Abstract Session 5: Mechanisms of AsthmaChair: Sally E. Wenzel, United States |
|
|
8:00 am – 8:20 am |
A Novel Machine Learning Pipeline Reveals Pathogenic Determinants of Systemic Adaptive Responses to Rhinovirus in Patients with Asthma |
Judith A. Woodfolk, United States |
|
8:20 am – 8:40 am |
Non-Type 2 Inflammatory Markers Predict Post-Operative Nasal Polyp Recurrence in Aspirin-Exacerbated Respiratory Disease |
Kathleen M. Buchheit, United States |
|
8:40 am – 9:00 am |
Plasma Siglec-6 as a Potential New Biomarker in Systemic Mastocytosis |
Gunnar Nilsson, Sweden |
|
9:00 am – 9:20 am |
Nasal Gene Expression Patterns Predict Responsiveness to Mepolizumab Therapy in Urban Children with Exacerbation Prone Asthma |
Daniel J. Jackson, United States |
|
9:20 am – 9:40 am |
Direct Activation of Airway Sensory C-fibers by SARS-CoV-2 Spike Protein |
Bradley J. Undem, United States |
|
9:40 am – 10:00 am |
Non-T2 cytokines, IL-1ß and IL-18 Drive Plasticity of Airway ILC2 to Intermediate ILC2/3 Phenotype in Severe Asthma with Neutrophilic or Mixed Granulocytic Bronchitis |
|
|
10:00 – 10:30 am |
Break |
|
10:30 am – 11:30 am |
Oral Abstract Session 6: Precision Medicine in AllergyChair: Thomas Bieber, Germany |
|
|
10:30 am – 10:50 am |
In Vivo Monitoring of Allergen-Specific Memory B-Cells: Tracking Development and Persistence |
Willem Van de Veen, Switzerland |
|
10:50 am – 11:10 am |
Tackling Allergy with Genome Engineering: Deleting Cat Allergen Fel d 1 Using CRISPR Editing |
Nicole Brackett, United States |
|
11:10 am – 11:30 am |
Janus Kinase Inhibitors Partly Restore the Toll-like Receptor 2 Responsiveness in Desensitized Human Langerhans Cells Via Down-regulation of Inhibitory Suppressor of Cytokine Signaling 1, but not Interleukin-1 Receptor Associated Kinase M |
Nadine Herrmann, Germany |
11:45 am – 12:30 pm |
CIA Business Meeting |
|
|
12:30 pm – 2:00 pm |
Lunch |
|
2:00 pm – 2:50 pm |
Paul Kallos Memorial Lecture: Microbial Future-proofing - How Early Life Microbiomes Shape Immune Function and Childhood AllergyChair: Joshua Boyce, United States |
Susan Lynch, United States |
|
2:50 pm – 3:15 pm |
Break |
|
3:15 pm – 5:15 pm |
Oral Abstract Session 7: Environmental Factors and PathophysiologyChair: Thomas A.E Platts-Mills, United States |
|
|
3:15 pm – 3:35 pm |
Allergen Exposure in Early Life is Associated with Systemic Immune Development in Disadvantaged Urban Children |
James E. Gern, United States |
|
3:35 pm – 3:55 pm |
Milk-Responsive T cells in Eosinophilic Esophagitis Display Unique Disease-Associated Cytokine Profiles in Both Tissue and Peripheral Blood |
Cecilia Berin, United States |
|
3:55 pm – 4:15 pm |
Human Germline Heterozygous Gain-of-Function STAT6 Variants Cause Severe Allergic Disease |
Stuart Turvey, Canada |
|
4:15 pm – 4:35 pm |
Patients with Aspirin Exacerbated Respiratory Disease are More Likely to have a Mixed Endotype and the R Allele of the Q576R Polymorphism than Patients with Chronic Rhinosinusitis with Nasal Polyps |
Whitney Stevens, United States |
|
4:35 pm – 4:55 pm |
Specific B cell Responses in Allergen-specific Immunotherapy |
Mubeccel Akdis, Switzerland |
|
4:55 pm – 5:15 pm |
Human IgE Monoclonal Antibody Interactions with Mite Allergen Der p 2 Define the Structural Basis for Anaphylaxis In Vivo |
Anna Pomés, United States |
7:00 pm |
Gala Dinner |
|
|
7:00 am – 8:00 am |
Breakfast |
|
8:00 am – 10:00 am |
Oral Abstract Session 8: Allergen Exposure and ImmunotherapyChair: Hans Oettgen, United States |
|
|
8:00 am – 8:20 am |
Plant-based Enveloped Ara h 2 Bioparticles Display Exceptional Hypo-allergenicity and Activate Human Dendritic Cells to Promote Th1 Cell Development |
Charlotte Castenmiller, Netherlands |
|
8:20 am – 8:40 am |
Oral Immunotherapy in Children Aged 1 to <4 Years with Peanut Allergy: POSEIDON Trial Outcomes, Including Age Stratification |
Andrea Vereda, Switzerland |
|
8:40 am – 9:00 am |
The Effect of Treatment Duration on Efficacy During Oral Immunotherapy Using Heat-Modified Peanut: Results from the BOPI (Boiled Peanut Oral Immunotherapy) Study |
Nandinee Patel, United Kingdom |
|
9:00 am – 9:20 am |
KLRG1hiIL17Rb1+ ILC2s Precede Eosinophil Recruitment into Remote Lungs Following Systemic Allergen Sensitization and Oral Allergen Challenge |
Lisa A. Spencer, United States |
|
9:20 am – 9:40 am |
IgA Exhibits Calcium- and Sialic Acid-dependent Binding to Mast Cells and Inhibits IgE-mediated Activation in an Antigen-Specific Fashion |
Yasmeen S. El Ansari, United States |
|
9:40 am – 10:00 am |
Characterizing Allergenicity and Immunogenicity of a Novel Peanut Allergen-Containing Enveloped Bioparticle |
Karina E. Canziani, United States |
|
10:00 am – 10:30 am |
Break |
|
10:30 am – 11:30 am |
Presidential Lecture: The Long and Winding Road to Siglec-based Therapeutic StrategiesChair: Thomas Bieber, Germany |
Bruce S. Bochner, United States |
11:30 am – 11:45 am |
Closing Remarks |
Thomas Bieber, Germany |
© 2024 Collegium Internationale Allergologicum. All rights reserved.
Privacy Notice | Website Terms of Use